No Detail Found!

Association Between -592 C/A Polymorphism of Interleukin 10 Gene and Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients

Author(s)
Muhammad Anees Department of Nephrology, Mayo Hospital,Lahore,Pakistan
Usman Ali Bajwa Department of Nephrology, Mayo Hospital,Lahore,Pakistan
Irfan Elahi Department of Nephrology, Mayo Hospital,Lahore,Pakistan
Muhammad Raza Department of Nephrology, Mayo Hospital,Lahore,Pakistan
Muhammad Shahbaz Pervaiz Department of Nephrology, Mayo Hospital,Lahore,Pakistan
Abstract
Objective: To establish the association between -592 C/A polymorphism of interleukin (IL) 10 gene and Diabetic Nephropathy (DNP) in Type 2 Diabetes Mellitus (T2DM) patients. Study Design: Comparative observational study. Place and Duration of the Study: Department of Nephrology (in collaboration with Biochemistry and Advanced Research Centre for Biomedical Sciences (ARCB)), Mayo Hospital and King Edward Medical University, Lahore, Pakistan, from January to December 2021. Methodology: The study included 282 patients with T2DM for e5 years, and aged e40 years. Patients with and without DNP were placed in Group A and B (n = 141 in each group), respectively. After drawing samples, deoxyribonucleic acid (DNA) was rst extracted from whole blood, then ampli ed via speci c primers, and nally genotyped through the polymerase chain reaction and restriction fragment length polymorphism (PCR RFLP) method. Median and interquartile range (IQR) were used to describe the skewed data and frequencies were used for categorical data. Mann-Whitney U test was used for comparison of data groups. Chi-square test was used to establish an association. Results: The median age of patients was 50.0 (12) years in Group A and 54.0 (11) years in Group B. Male-to-female distribution was 39 (27.7%) / 102 (72.3%) in Group A and 49 (34.8%) / 92 (65.2%) in Group B. The -592 C/A polymorphism ofIL 10 genes was found more frequently in Group A 72 (51.0%) than Group B 63 (44.7%) without statistical signi cance (p = 0.283). Conclusion: The current study showed that the presence of single nucleotide C/A polymorphism at the -592 position ofIL 10 gene in T2DM patients does not in uence (increase / decrease) their susceptibility to develop DNP.
Publication Details
Page(s) 147-151
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 35, Issue: 2, Year: 2025

Request the full text from PASTIC

Keywords
type 2 diabetes mellitus, Diabetic Nephropathy, Single nucleotide polymorphism, Interleukin-10, -592 C/A
References
Harreiter J,Roden M .2023 .]. Wien Klin Wochenschr, 10(Suppl 1) : 022-17.
Saeedi P,Petersohn I,Salpea P,Malanda B,Karuranga S,Unwin N .2019 .Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the international diabetes federation diabetes Atlas, 9th edition. Diabetes Res Clin Pract, 107843 : 107843.
Goyal R,Singhal M,Jialal I. .2024 .Type 2 diabetes. 2023 Jun 23. , : .
Elendu C,Okah MJ,Fiemotongha KDJ,Adeyemo BI,Bassey BN,Omeludike EK .2023 .Comprehensive advancements in the prevention and treatment of diabetic nephropathy: A narrative review. Medicine (Baltimore), 10(40) : .
Agarwal R .2021 .Chronic kidney disease and type 2 diabetes. , : .
Samsu N. .2021 .Diabetic nephropathy: Challenges in pathogenesis, diagnosis, and treatment. Biomed Res Int, 10 : .
Correa JD,Ferri CM,Quintana FS,Castro AP,Luis AG,Nunez EM .2020 .et a.l In ammatory cytokines in diabetic kidney disease: Pathophysiologic and therapeutic implications. Front Med, 628289 : 628289.
Sandholm N,Dahlstrom EH,Groop PH .2023 .Genetic and epigenetic background of diabetic kidney diseaseF. ront Endocrinol (Lausanne), 1163001 : 1163001.
Hayat S,Asad A,Munni MA,Nayeem MAJ,Mostafa MG,Jahan I .2024 .-10 promoter polymorphisms and haplotypes in patients with Guillain-Barre syndrome. Ann Clin Transl Neurol, 10(1) : 51939-42.
Babel N,Gabdrakhmanova L,Hammer MH,Schoenemann C,Skrypnikov V,Poliak N .2006 .Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease. J Nephrol, 19(6) : 802-7.
Ezzidi I,Mtiraoui N,Kacem M,Mallat SG,Mohamed MB,Chaieb M .2008 .G promoter variants a ect the susceptibility to nephropathy in tunisian type 2 diabetes (T2DM) patients. Clin Endocrinol (Oxf), 03337(3) : 2265-7.
Arababadi MK,Mirzaei MR,Sajadi SMA,Hassanshahi G,Ahmadabadi BN,Salehabadi VA .2012 .-10 gene polymorphisms are associated with type 2 diabetes with and without nephropathy: A study of patients from the southeast region of Iran. Interleukin, 10(3) : 797-802.
Erdogan M,Cetinkalp S,Ozgen AG,Saygili F,Berdeli A,Yilmaz C .2011 .-1082G/A) gene polymorphism in patients with type 2 diabetes with and without nephropathy. Genet Test Mol Biomarkers, 0075(2) : 91-4.
Chang YH,Huang CN,Wu CY,Shiau MY .2005 .Association of interleukin-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus. Hum Immunol, 05(12) : 1258-63.
Buenrostro LEC,Bello JH,Valle JFM,Barragan JM,Carrillo LBH,Reyes JFT .2019 .IL10 haplotypes are associated with diabetic nephropathy susceptibility in patients from Western Mexico. J Clin Lab Anal, 10(2) : .
Claussnitzer M,Cho JH,Collins R,Cox NJ,Dermitzakis ET,Hurles ME .2020 .A brief history of human disease genetics. Nature, 10(7789) : 179-89.
Tziastoudi M,Stefanidis I,Zintzaras E. .2020 .The genetic map of diabetic nephropathy: Evidence from a systematic review and meta-analysis of genetic association studies. Clin Kidney J, 10(5) : 768-81.
Fontalvo JR,Aroca G,Cabrales J,Arnedo RD,Rodriguez TY,Avila MCM .2022 .Molecular mechanisms of diabetic kidney disease. Int J Mol Sci, 10(15) : 8668.
Bakheet MS .2017 .Interleukin 10 gene polymorphisms and susceptibility to nephropathy in Egyptian diabetic patients. Int J Bioc Res, 10(4) : 1-11.
Naing C,Htet NH,Basavaraj AK,Nalliah S. .2018 .An association between IL-10 promoter polymorphisms and diabetic nephropathy: A meta-analysis of case-control studies. J Diabetes Metab Disord, 10(2) : 333-43.
Zhang X,Zhang J,Ren Y,Sun R,Zhai X .2024 .Unveiling the pathogenesis and therapeutic approaches for diabetic nephropathy: Insights from panvascular diseases. Front Endocrinol (Lausanne), 1368481 : 1368481.
Dong H,Li Q,Wang M,Wan G .2015 .Association between IL-10 Gene [olymorphism and diabetic retinopathy. Med Sci Monit, 10 : 3203-8.
Zhu LJ,Liu ZH,Zeng CH,Chen ZH,Yu C,Li LS .2005 .Association of interleukin-10 gene -592 A/C polymorphism with the clinical and pathological diversity of lupus nephritis. Clin Exp Rheumatol, 23(6) : 854-60.
Moudi B,Heidari Z,Sagheb HM,Hashemi M,Metanat M,Khosravi S,A S .2016 .susceptibility to HBV infection in an Iranian population. Hepat Mon, 10(2) : .
Diakite B,Kassogue Y,Maiga M,Dolo G,Kassogue O,Musa J .2022 .Association of the Interleukin-10-592C/A polymorphism and cervical cancer risk: A meta-analysis. Genet Res (Camb), 10 : .
0

Citations

0

Downloads

129

Views